CARISMA THERAPEUTICS

carisma-therapeutics-logo

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors. Its cell therapies apply powerful chimeric antigen receptor technology and adoptive cell transfer in cancer therapy and to macrophages that infiltrate the solid tumor micro-environment that enables solid tumor patients to receive strong cellular immunotherapy and cancer treatments. The company's technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy for the treatment of human disease. Founded in 2016 by Michael Klichinsky and Saar Gill, Carisma Therapeutics is headquartered in Philadelphia, Pennsylvania.

#SimilarOrganizations #People #Financial #Event #Website #More

CARISMA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science Medical Therapeutics

Founded:
2016-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Website Url:
http://www.carismatx.com

Total Employee:
11+

Status:
Active

Contact:
484-899-0326

Email Addresses:
[email protected]

Total Funding:
121.85 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Euro Google Maps US Privacy User Signal Mechanism Google Maps API AdBlock Acceptable Ads Google Maps Embed


Similar Organizations

juno-therapeutics-logo

Juno Therapeutics

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.


Current Advisors List

not_available_image

Althea Stillman Board of Directors @ Carisma Therapeutics
Board_member

margarita-chavez_image

Margarita Chavez Board of Directors @ Carisma Therapeutics
Board_member

regina-hodits_image

Regina Hodits Board of Directors @ Carisma Therapeutics
Board_member

eran-nadav_image

Eran Nadav Board of Directors @ Carisma Therapeutics
Board_member

jacob-gunterberg_image

Jacob Gunterberg Board of Directors @ Carisma Therapeutics
Board_member

Current Employees Featured

saar-gill_image

Saar Gill
Saar Gill Co-Founder @ Carisma Therapeutics
Co-Founder
2016-01-01

steven-kelly_image

Steven Kelly
Steven Kelly President & Chief Executive Officer @ Carisma Therapeutics
President & Chief Executive Officer
2018-02-01

bruce-a-peacock_image

Bruce A. Peacock
Bruce A. Peacock Executive Chairman @ Carisma Therapeutics
Executive Chairman

tom-wilton_image

Tom Wilton
Tom Wilton CBO @ Carisma Therapeutics
CBO

debora-barton_image

Debora Barton
Debora Barton CMO @ Carisma Therapeutics
CMO

daniel-cushing_image

Daniel Cushing
Daniel Cushing CTO & CDO @ Carisma Therapeutics
CTO & CDO

michael-klichinsky_image

Michael Klichinsky
Michael Klichinsky Co-Founder and Chief Scientific Officer @ Carisma Therapeutics
Co-Founder and Chief Scientific Officer
2022-04-01

jacob-gunterberg_image

Jacob Gunterberg
Jacob Gunterberg Director @ Carisma Therapeutics
Director
2018-06-01

kenneth-locke_image

Kenneth Locke
Kenneth Locke VP, Manufacturing @ Carisma Therapeutics
VP, Manufacturing
2020-06-01

Founder


michael-klichinsky_image

Michael Klichinsky

saar-gill_image

Saar Gill

Investors List

abbvie-biotech-ventures_image

AbbVie Biotech Ventures

AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics

ip-group-plc_image

IP Group

IP Group investment in Series B - Carisma Therapeutics

healthcap_image

HealthCap

HealthCap investment in Series B - Carisma Therapeutics

agent-capital_image

Agent Capital

Agent Capital investment in Series B - Carisma Therapeutics

wellington-partners_image

Wellington Partners

Wellington Partners investment in Series B - Carisma Therapeutics

penn-medicine-co-investment-fund_image

Penn Medicine Co-Investment Program

Penn Medicine Co-Investment Program investment in Series B - Carisma Therapeutics

livzon-pharmaceutical-group_image

Livzon Pharmaceutical Group

Livzon Pharmaceutical Group investment in Series B - Carisma Therapeutics

4bio-capital-partners_image

4BIO Capital

4BIO Capital investment in Series B - Carisma Therapeutics

solasta-ventures_image

Solasta Ventures

Solasta Ventures investment in Series B - Carisma Therapeutics

symbiosis-ii-llc_image

SymBiosis LLC

SymBiosis LLC investment in Series B - Carisma Therapeutics

Official Site Inspections

http://www.carismatx.com Semrush global rank: 7.81 M Semrush visits lastest month: 437

  • Host name: cloudproxy10062.sucuri.net
  • IP address: 192.124.249.62
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Carisma Therapeutics" on Search Engine